WELLS DAVID B 4

What Happened
David B. Wells, a director of Hims & Hers Health, Inc. (HIMS), was granted 957 restricted stock units (RSUs) on 2026-05-20. The RSUs were issued as compensation in lieu of cash fees and carry an implied value of about $22,000 (based on a grant price of $22.98). The filing reports the award as a derivative grant (acquisition at $0.00) — no cash was paid; the RSUs convert to one share of Class A common stock each when vested.

Key Details

• Transaction date: 2026-05-20; Form 4 filed 2026-05-22 (filed within the usual 2-business-day reporting window).
• Grant amount: 957 RSUs (derivative award reported at $0.00 acquisition price).
• Implied value: roughly $22,000 (grant price used for calculation: $22.98).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — each RSU = contingent right to one share of Class A common stock; F2 — RSUs issued under the Issuer's Director Compensation Policy in lieu of Q1 2026 fees, calculated by dividing $22,000 of foregone cash fees by a $22.98 grant price; RSUs vest in full on the company's next quarterly vesting date.

Context
This was a routine compensation award to a director rather than an open-market purchase or sale. RSU grants do not represent immediate stock ownership until they vest and convert to shares; they are commonly used to compensate directors and align long-term incentives.